Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index; 32 of the 47 sources its claims cite were checked for support.
Abstract
Imaging technologies are being increasingly used in biomedical research and experimental toxicology to gather morphological and functional information from cellular models. There is a concrete opportunity of incorporating imaging-based in vitro methods in international guidelines to respond to regulatory requirements with human relevant data. To translate these methods from R&D to international regulatory acceptance, the community needs to implement test methods under quality management systems, assess inter-laboratory transferability, and demonstrate data reliability and robustness. This article summarises current challenges associated with image acquisition, image analysis, including artificial intelligence, and data management of imaging-based methods, with examples from the developmental neurotoxicity in vitro battery and phenotypic profiling assays. The article includes considerations on specific needs and potential solutions to design and implement future validation and transferability studies.
Overview
CoChat Summary
TL;DR
This review/perspective summarizes challenges and recommendations for translating imaging-based in vitro methods from biomedical research to regulatory toxicology, focusing on image acquisition, analysis/AI, metadata, data management, transferability, reproducibility, and quality assurance. It uses the developmental neurotoxicity in vitro battery and phenotypic profiling/Cell Painting as examples and argues that standardisation, validation, and transparent reporting are needed for OECD test guideline acceptance.
Key findings
- Imaging-based in vitro methods generate digital images that require processing and analysis; regulatory acceptance requires implementation under quality management systems, assessment of inter-laboratory transferability, and demonstration of data reliability and robustness.
- The developmental neurotoxicity in vitro battery (DNT IVB) was supported by EFSA, which funded assessment of 120 substances; OECD proposed approximately 100 chemicals as DNT reference chemicals, and performance analysis confirmed high reproducibility and accuracy while identifying needs for glia-specific toxicity methods and exclusively human-based cell systems.
- Cell Painting/phenotypic profiling has been tested on over 1000 chemicals, with profiles available in the EPA CompTox Chemicals Dashboard; in vitro points-of-departure from human cells were similar or more conservative than in vivo animal points-of-departure for 68% of chemicals tested.
- Recommendations include systematic instrument calibration, standardised open formats (e.g., OME.tiff, OME-Zarr, DICOM), comprehensive metadata and ontologies, data management plans, GLP-compatible archiving (up to 15 years in some jurisdictions), and transparent AI validation; a sensitivity/specificity balance of around 80% for both is usually accepted for regulatory decision-making.
Methods
- Narrative review/perspective; no primary experimental data are reported. It synthesizes current challenges and platform-agnostic recommendations across the imaging workflow, with examples from the DNT IVB and phenotypic profiling/Cell Painting.
- Draws on cited literature, OECD guidance documents (e.g., GD34, GIVIMP), FDA/ICH/IVDR frameworks, and community initiatives (e.g., QUAREP-LiMi, Euro-BioImaging, Bigpicture); no sample, dataset, or statistical analysis is described.
Limitations
- The paper states that considerations on the choice of the best biological model and downstream data analysis of parameters extracted from images are out of scope; the focus is on technology and the imaging workflow.
- The paper states that existing GLP principles may not be fully applicable to emerging technologies, that capturing comprehensive metadata remains a challenge, that commercial software’s proprietary algorithms limit transparency, and that systematic instrument calibration is often overlooked.
- Evident from the text: as a review/perspective, the recommendations are not empirically validated in a single study, and no formal limitations section or primary data are presented; regulatory acceptance pathways for imaging-based in vitro methods remain aspirational.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
21 Valid · 1 Not valid · 10 Not checked · 32 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Recently, a DNT in vitro battery (DNT IVB) has been assembled (Sachana, Shafer, and Terron 2021; Harrill et al. 2018; Blum et al. 2023), comprising of multiple test methods assessing individual key neurodevelopmental processes (KNDPs).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Introduction > Use of imaging technologies in medical regulated fields
What the sources say
- Supportedcites Sachana, Shafer, and Terron 2021 matched to “Toward a Better Testing Paradigm for Developmental Neurotoxicity: OECD Efforts and Regulatory Considerations” (2021) source
Section 3 says the DNT in vitro battery includes multiple assays designed around key neurodevelopmental processes. Section 3.1 states that each assay evaluates a key neurodevelopmental event, and the Conclusions state that multiple tests have been assembled into a battery. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites Harrill et al. 2018 matched to “Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment” (2018) source
- Not checked — no full text of the sourcecites Blum et al. 2023 matched to “Establishment of a human cell-based in vitro battery to assess developmental neurotoxicity hazard of chemicals” (2023) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In vitro points-of-departures derived from human cells with CP were similar or more conservative than in vivo animal points-of-departure for 68% of the chemical tested (Nyffeler et al. 2020).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Introduction > Use of imaging technologies in medical regulated fields
What the sources say
- Supportedcites Nyffeler et al. 2020 matched to “Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling” (2020) source
The Results report that Cell Painting-derived HTPP administered equivalent doses were conservative or comparable to in vivo points of departure for 68% (285/420) of chemicals with the data needed for comparison. The Introduction identifies the assay cells as human-derived; the 68% denominator is the 420 comparable chemicals, not all 462 screened. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Data generated using the DNT IVB has been used for hazard identification in EFSA-coordinated case studies on pesticides such as deltamethrin, acetamiprid, and flufenacet. (OECD 2023a; EFSA et al. 2024).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Introduction > Use of imaging technologies in medical regulated fields
What the sources say
- Not matchedcites OECD 2023a
More than one paper fits this citation.
- Supportedcites EFSA et al. 2024 matched to “Statement on the toxicological properties and maximum residue levels of acetamiprid and its metabolites” (2024) source
The Recommendations > Human health section names EFSA’s three pesticide IATA case studies—deltamethrin, flufenacet and acetamiprid—and describes the framework as an approach to DNT hazard identification that integrates DNT IVB results. The Hazard assessment acetamiprid section also states that acetamiprid was tested in all DNT IVB assays. Page numbers were not available in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The current testing paradigm for DNT mainly relies on results on results from in vivo guideline studies (OECD TG 426 (OECD 2007), OECD TG 443 with DNT cohort (OECD 2018a)).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Introduction > Use of imaging technologies in medical regulated fields
What the sources say
- Supportedcites OECD 2007 matched to “Test No. 426: Developmental Neurotoxicity Study” (2007) source
This citation identifies OECD TG 426 as an in vivo developmental neurotoxicity guideline study. Sections 2 and 3 describe its study of offspring exposed during development and require compliance with guidelines for laboratory animal research. The separate citation to OECD 2018a is attached to TG 443; this source is not being cited to identify that guideline. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites OECD 2018a matched to “Guidance Document on Good In Vitro Method Practices (GIVIMP)” (2018) source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Capturing comprehensive metadata throughout the experimental workflow remains a challenge, as highlighted in a recent survey (Schmidt et al. 2022).”
§ Bridging imaging-based in vitro methods from biomedical research to regulatory toxicology > Imaging-based in vitro methods towards regulatory use
What the sources say
- Supportedcites Schmidt et al. 2022 matched to “Research data management for bioimaging: the 2021 NFDI4BIOIMAGE community survey” (2022) source
In Results and discussion (page unavailable), the survey reports that many respondents collect no metadata beyond what instruments save automatically, and that tools and guidelines for annotation are lacking. The Conclusions describe integrating metadata practices into the research data life cycle as an ongoing challenge. Together, these support the claim about capturing comprehensive metadata across the workflow. (LLM, conf=0.89)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
7 more claims · 3 with their cited sources checked
Create a free account to see all 64 claims and every source verdict.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 40
Citations
Cites
ImageJ2: ImageJ for the next generation of scientific image data
Rueden, C. T., Schindelin, J., Hiner, M. C., DeZonia, B. E., Walter, A. E., Arena, E. T., & Eliceiri, K. W. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1934-z · Cited by 5,980 · cited 2×
“Open-source solutions based on software platforms such as Fiji/ImageJ (Rueden et al. 2017), CellProfiler (Stir-ling et al. 2021; Soliman 2015) and pipelining software KNIME (Berthold et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific use cases, which can…”
The Principles of Humane Experimental Technique
(1960) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1960.tb73127.x · Cited by 4,912
CellProfiler 4: improvements in speed, utility and usability
Stirling, D. R., Swain-Bowden, M. J., Lucas, A. M., Carpenter, A. E., Cimini, B. A., & Goodman, A. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04344-9 · Cited by 2,070
KNIME: The Konstanz Information Miner
Berthold, M. R., Cebron, N., Dill, F., Gabriel, T. R., Kötter, T., Meinl, T., Ohl, P., Sieb, C., Thiel, K., & Wiswedel, B. (2008) · Studies in Classification, Data Analysis, and Knowledge Organization · doi:10.1007/978-3-540-78246-9_38 · Cited by 1,251 · cited 2×
“…on software platforms such as Fiji/ImageJ (Rueden et al. 2017), CellProfiler (Stir-ling et al. 2021; Soliman 2015) and pipelining software KNIME (Berthold et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific use cases, which can…”
Deep learning for cellular image analysis
Moen, E., Bannon, D., Kudo, T., Graf, W., Covert, M., & Van Valen, D. (2019) · Nature Methods · doi:10.1038/s41592-019-0403-1 · Cited by 1,225 · cited 1×
“Recently DL, a specialised form of ML algorithms using Deep Neural Networks, is increasingly applied for microscopy image and data analysis (Moen et al. 2019; Seo et al. 2020).”
KNIME - the Konstanz information miner: version 2.0 and beyond
Berthold, M. R., Cebron, N., Dill, F., Gabriel, T. R., Kötter, T., Meinl, T., Ohl, P., Thiel, K., & Wiswedel, B. (2009) · ACM SIGKDD Explorations Newsletter · doi:10.1145/1656274.1656280 · Cited by 1,189
Bray, M.-A., Singh, S., Han, H., Davis, C. T., Borgeson, B., Hartland, C., Kost-Alimova, M., Gustafsdottir, S. M., Gibson, C. C., & Carpenter, A. E. (2016) · Nature Protocols · doi:10.1038/nprot.2016.105 · Cited by 1,090
Metadata matters: access to image data in the real world
Linkert, M., Rueden, C. T., Allan, C., Burel, J.-M., Moore, W., Patterson, A., Loranger, B., Moore, J., Neves, C., MacDonald, D., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201004104 · Cited by 1,018 · cited 1×
“Metadata should be embedded within the image file itself or provided in supplementary files alongside the published images (Linkert et al. 2010; Hammer et al. 2021).”
Self-citationEBImage—an R package for image processing with applications to cellular phenotypes
Pau, G., Fuchs, F., Sklyar, O., Boutros, M., & Huber, W. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq046 · Cited by 797 · cited 1×
“…et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific use cases, which can become particularly powerful when combined with open-source data analysis based on R (Meyer et al. 2024; Pau et al. 2010) or Python (Rueden et al. 2022).”
Data-analysis strategies for image-based cell profiling
Caicedo, J. C., Cooper, S., Heigwer, F., Warchal, S., Qiu, P., Molnar, C., Vasilevich, A. S., Barry, J. D., Bansal, H. S., Kraus, O., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4397 · Cited by 739 · cited 1×
“For this purpose, the generated microscopy images are used to extract many different image features using Machine Learning (ML) approaches based on handcrafted features and more recently using DL (Caicedo et al. 2017; Chan-drasekaran et al. 2021).”
OMERO: flexible, model-driven data management for experimental biology
Allan, C., Burel, J.-M., Moore, J., Blackburn, C., Linkert, M., Loynton, S., MacDonald, D., Moore, W. J., Neves, C., Patterson, A., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1896 · Cited by 653 · cited 4×
“Using existing image data management systems like Open Microscopy Environment Remote Objects (OMERO) (Allan et al. 2012; Burel et al. 2015; Li et al. 2016) and storing biological image datasets in repositories ( e.g., BioImage Archive, 17 IDR, 18 PIDAR 19 ) can facilitate secure data sharing and…”
InfluentialSelf-citationVirtual histological staining of unlabelled tissue-autofluorescence images via deep learning
Rivenson, Y., Wang, H., Wei, Z., de Haan, K., Zhang, Y., Wu, Y., Günaydın, H., Zuckerman, J. E., Chong, T., Sisk, A. E., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0362-y · Cited by 640 · cited 1×
“Virtual Virtual staining overcomes the limitations of manual staining workflows (time consuming, staining variability, small tissue size) by using computational algorithms to generate digital representations of various staining techniques on unstained sections (Rivenson et al. 2019).”
Metrics reloaded: recommendations for image analysis validation
Maier-Hein, L., Reinke, A., Godau, P., Tizabi, M. D., Buettner, F., Christodoulou, E., Glocker, B., Isensee, F., Kleesiek, J., Kozubek, M., et al. (2024) · Nature Methods · doi:10.1038/s41592-023-02151-z · Cited by 470
Image-based profiling for drug discovery: due for a machine-learning upgrade?
Chandrasekaran, S. N., Ceulemans, H., Boyd, J. D., & Carpenter, A. E. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00117-w · Cited by 389
The Tox21 10K Compound Library: Collaborative Chemistry Advancing Toxicology
Richard, A. M., Huang, R., Waidyanatha, S., Shinn, P., Collins, B. J., Thillainadarajah, I., Grulke, C. M., Williams, A. J., Lougee, R. R., Judson, R. S., et al. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00264 · Cited by 323 · cited 1×
“With a similar reasoning, the Tox21 consortium was founded by a group of US agencies with the goal of using high throughput screening to generate data on data-poor compounds for safety assessment (Richard et al. 2021; Ngan et al. 2023; Sakamuru et al. 2022).”
Image Data Resource: a bioimage data integration and publication platform
Williams, E., Moore, J., Li, S. W., Rustici, G., Tarkowska, A., Chessel, A., Leo, S., Antal, B., Ferguson, R. K., Sarkans, U., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4326 · Cited by 314 · cited 3×
“Examples of existing image repositories can be found here (OMERO (Allan et al. 2012; Burel et al. 2015; Li et al. 2016), the BioImage Archive e (Hartley et al. 2022), IDR (Williams et al. 2017), and PIDAR f ).”
Self-citationSeo, H., Badiei Khuzani, M., Vasudevan, V., Huang, C., Ren, H., Xiao, R., Jia, X., & Xing, L. (2020) · Medical Physics · doi:10.1002/mp.13649 · Cited by 300 · cited 1×
“Recently DL, a specialised form of ML algorithms using Deep Neural Networks, is increasingly applied for microscopy image and data analysis (Moen et al. 2019; Seo et al. 2020).”
Multiplex Cytological Profiling Assay to Measure Diverse Cellular States
Gustafsdottir, S. M., Ljosa, V., Sokolnicki, K. L., Anthony Wilson, J., Walpita, D., Kemp, M. M., Petri Seiler, K., Carrel, H. A., Golub, T. R., Schreiber, S. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080999 · Cited by 291 · cited 2×
“The concept of PP was pioneered by the laboratory of A.E. Carpenter at the Broad Institute of Harvard and MIT (Gustafsdottir et al. 2013; Bray et al. 2016) and has quickly been successfully implemented, optimised, and standardised for high-throughput phenotypic profiling at various sites worldwide (Cimini et al. 2023;…”
McGenity, C., Clarke, E. L., Jennings, C., Matthews, G., Cartlidge, C., Freduah-Agyemang, H., Stocken, D. D., & Treanor, D. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01106-8 · Cited by 290 · cited 1×
“The performance of the ML/DL model used for image analysis should be accurately measured with problem-specific metrics, some guidance on different approaches and recommendations can be found in (Laine et al. 2021; Maier-Hein et al. 2024; McGenity et al. 2024).”
Digital pathology and computational image analysis in nephropathology
Barisoni, L., Lafata, K. J., Hewitt, S. M., Madabhushi, A., & Balis, U. G. J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0321-6 · Cited by 264 · cited 1×
“Some countries, such as Japan, China, and India, have established or are developing their own regulatory frameworks for digital pathology, while others, such as Brazil, Mexico, and South Africa, are following or adapting the international standards and guidelines (Barisoni et al. 2020).”
Bal-Price, A. (2018) · ALTEX · doi:10.14573/altex.1712081 · Cited by 207
OECD (2005) · OECD Series on Testing and Assessment · doi:10.1787/e1f1244b-en · Cited by 207
OME-NGFF: a next-generation file format for expanding bioimaging data-access strategies
Moore, J., Allan, C., Besson, S., Burel, J.-M., Diel, E., Gault, D., Kozlowski, K., Lindner, D., Linkert, M., Manz, T., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01326-w · Cited by 183 · cited 1×
“The use of standardised open data formats like OME.tiff (Hammer et al. 2021), OME-Zarr (Moore et al. 2021), DICOM a (mainly used in digital pathology) should be adopted across organisations and geographical boundaries.”
Self-citationOptimizing the Cell Painting assay for image-based profiling
Cimini, B. A., Chandrasekaran, S. N., Kost-Alimova, M., Miller, L., Goodale, A., Fritchman, B., Byrne, P., Garg, S., Jamali, N., Logan, D. J., et al. (2023) · Nature Protocols · doi:10.1038/s41596-023-00840-9 · Cited by 177 · cited 2×
“…of A.E. Carpenter at the Broad Institute of Harvard and MIT (Gustafsdottir et al. 2013; Bray et al. 2016) and has quickly been successfully implemented, optimised, and standardised for high-throughput phenotypic profiling at various sites worldwide (Cimini et al. 2023; Tromans-Coia et al. 2023).”
Crofton, K. (2010) · ALTEX · doi:10.14573/altex.2011.1.009 · Cited by 168
Guidance Document on Good In Vitro Method Practices (GIVIMP)
OECD (2018) · OECD Series on Testing and Assessment · doi:10.1787/9789264304796-en · Cited by 161
The BioImage Archive – Building a Home for Life-Sciences Microscopy Data
Hartley, M., Kleywegt, G. J., Patwardhan, A., Sarkans, U., Swedlow, J. R., & Brazma, A. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167505 · Cited by 159
Self-citationChandrasekaran, S. N., Cimini, B. A., Goodale, A., Miller, L., Kost-Alimova, M., Jamali, N., Doench, J. G., Fritchman, B., Skepner, A., Melanson, M., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02241-6 · Cited by 154 · cited 1×
“…create the worldwide largest CP-based image dataset and phenotypic profiles for hundreds of thousands of small molecules, industrial/agricultural chemicals or genetic perturbations, which will eventually become publicly available as resource datasets (Chandrasekaran et al. 2024; Wolff et al. 2024).”
Pistollato, F., Madia, F., Corvi, R., Munn, S., Grignard, E., Paini, A., Worth, A., Bal-Price, A., Prieto, P., Casati, S., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03034-y · Cited by 137 · cited 1×
“…discuss technical and biological variability, concordance with in vivo data, and frameworks for building confidence in in vitro methods for risk assessment and regulatory purposes (National Academies of Sciences and Medicine 2023; Senft et al. 2023; Negro et al. 2018; Pistollato et al. 2021).”
Best practices and tools for reporting reproducible fluorescence microscopy methods
Llopis, P. D. L. M. M., Senft, R. A., Ross-Elliott, T. J., Stephansky, R., Keeley, D. P., Koshar, P., Marqués, G., Gao, Y., Carlson, B. R., Pengo, T., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01156-w · Cited by 137 · cited 4×
“…and clear reporting templates were already proposed in the literature (Nelson et al. 2021; Schmied et al. 2024; Sarkans et al. 2021; Montero Llopis et al. 2021) and they are an optimal starting point to develop reporting templates and guidelines that are specific for regulatory use and…”
InfluentialNyffeler, J., Willis, C., Lougee, R., Richard, A., Paul-Friedman, K., & Harrill, J. A. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114876 · Cited by 136 · cited 1×
“In vitro points-of-departures derived from human cells with CP were similar or more conservative than in vivo animal points-of-departure for 68% of the chemical tested (Nyffeler et al. 2020).”
Self-citationPamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127 · cited 1×
“…Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
REMBI: Recommended Metadata for Biological Images—enabling reuse of microscopy data in biology
Sarkans, U., Chiu, W., Collinson, L., Darrow, M. C., Ellenberg, J., Grunwald, D., Hériché, J.-K., Iudin, A., Martins, G. G., Meehan, T., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01166-8 · Cited by 126 · cited 4×
“Very comprehensive and clear reporting templates were already proposed in the literature (Nelson et al. 2021; Schmied et al. 2024; Sarkans et al. 2021; Montero Llopis et al. 2021) and they are an optimal starting point to develop reporting templates and guidelines that are specific for regulatory…”
InfluentialSelf-citationŻuraw, A., & Aeffner, F. (2021) · Veterinary Pathology · doi:10.1177/03009858211040484 · Cited by 120
Community-developed checklists for publishing images and image analyses
Schmied, C., Nelson, M. S., Avilov, S., Bakker, G., Bertocchi, C., Bischof, J., Boehm, U., Brocher, J., Carvalho, M. T., Chiritescu, C., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-01987-9 · Cited by 120 · cited 2×
“…for standardisation in imaging technologies, organisations such as Global BioImaging 6 and QUAREP-LiMi 7 (Quality assurance and reproducibility for instrument and images in light microscopy) facilitate best practices and collaboration across stakeholders (Nelson et al. 2021; Schmied et al. 2024).”
Self-citationAvoiding a replication crisis in deep-learning-based bioimage analysis
Laine, R. F., Arganda-Carreras, I., Henriques, R., & Jacquemet, G. (2021) · Nature Methods · doi:10.1038/s41592-021-01284-3 · Cited by 113 · cited 1×
“The performance of the ML/DL model used for image analysis should be accurately measured with problem-specific metrics, some guidance on different approaches and recommendations can be found in (Laine et al. 2021; Maier-Hein et al. 2024; McGenity et al. 2024).”
Masjosthusmann, S., Blum, J., Bartmann, K., Dolde, X., Holzer, A., Stürzl, L., Keßel, E. H., Förster, N., Dönmez, A., Klose, J., et al. (2020) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2020.en-1938 · Cited by 110 · cited 1×
“The integration of test methods identifying glia cell-specific toxicities ( i.e., astrocytes, radial glia, and microglia) and the use of exclusively human-based cell systems shall improve the DNT IVB performance in the future (Masjosthusmann et al. 2020; Serafini et al. 2024).”
A call for public archives for biological image data
Ellenberg, J., Swedlow, J. R., Barlow, M., Cook, C. E., Sarkans, U., Patwardhan, A., Brazma, A., & Birney, E. (2018) · Nature Methods · doi:10.1038/s41592-018-0195-8 · Cited by 107 · cited 1×
“…(OMERO) (Allan et al. 2012; Burel et al. 2015; Li et al. 2016) and storing biological image datasets in repositories ( e.g., BioImage Archive, 17 IDR, 18 PIDAR 19 ) can facilitate secure data sharing and foster collaboration (Williams et al. 2017; Ellenberg et al. 2018; Hart-ley et al. 2022).”
Self-citationTest No. 426: Developmental Neurotoxicity Study
OECD (2007) · OECD Guidelines for the Testing of Chemicals, Section 4 · doi:10.1787/9789264067394-en · Cited by 107
Expanding the test set: Chemicals with potential to disrupt mammalian brain development
Mundy, W. R., Padilla, S., Breier, J. M., Crofton, K. M., Gilbert, M. E., Herr, D. W., Jensen, K. F., Radio, N. M., Raffaele, K. C., Schumacher, K., et al. (2015) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2015.10.001 · Cited by 105 · cited 1×
“Mundy et al. 2015)).”
Harrill, J. A., Viant, M. R., Yauk, C. L., Sachana, M., Gant, T. W., Auerbach, S. S., Beger, R. D., Bouhifd, M., O'Brien, J., Burgoon, L., et al. (2021) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2021.105020 · Cited by 105 · cited 1×
“In the field of omics, another emerging technology with the potential to widely impact regulatory sciences, the OECD is developing templates for data reporting (Harrill et al. 2021; OECD 2023b).”
Self-citationBlum, J., Masjosthusmann, S., Bartmann, K., Bendt, F., Dolde, X., Dönmez, A., Förster, N., Holzer, A.-K., Hübenthal, U., Keßel, H. E., et al. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2022.137035 · Cited by 105
Self-citationGuidance document on Good cell and tissue culture practice 2.0 (GCCP 2.0)
Pamies, D. (2021) · ALTEX · doi:10.14573/altex.2111011 · Cited by 100 · cited 2×
“Comple-mentarily, Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
Evaluating batch correction methods for image-based cell profiling
Arevalo, J., Su, E., van Dijk, R., Carpenter, A. E., & Singh, S. (2023) · doi:10.1101/2023.09.15.558001 · Cited by 89 · cited 1×
“…culture conditions ( e.g., cell density at the imaging stage), solvent percentage ( e.g., different amount of DMSO), staining procedure, ( e.g., dye signal stability over time), and finally from the use of different microscopy systems and data analysis software and approaches (Arevalo et al. 2024).”
Pamies, D., Ekert, J., Zurich, M.-G., Frey, O., Werner, S., Piergiovanni, M., Freedman, B. S., Keong Teo, A. K., Erfurth, H., Reyes, D. R., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.03.009 · Cited by 88 · cited 2×
“…Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et al. 2024).”
Self-citationHarrill, J. A., Freudenrich, T., Wallace, K., Ball, K., Shafer, T. J., & Mundy, W. R. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.04.001 · Cited by 86 · cited 1×
“Recently, a DNT in vitro battery (DNT IVB) has been assembled (Sachana, Shafer, and Terron 2021; Harrill et al. 2018; Blum et al. 2023), comprising of multiple test methods assessing individual key neurodevelopmental processes (KNDPs).”
Evaluating batch correction methods for image-based cell profiling
Arevalo, J., Su, E., Ewald, J. D., van Dijk, R., Carpenter, A. E., & Singh, S. (2024) · Nature Communications · doi:10.1038/s41467-024-50613-5 · Cited by 86
Schmuck, M. R., Temme, T., Dach, K., de Boer, D., Barenys, M., Bendt, F., Mosig, A., & Fritsche, E. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1852-2 · Cited by 84 · cited 2×
“…the differentiation and morphology of neurons, and the differentiation of oligodendrocytes is assessed based on brightfield images and immuno-cytochemical staining using the image analysis software ‘Omnisphero’ (Schmuck et al. 2017; Förster et al. 2022) and two Convolutional Neural Networks (CNN).”
https://www.altex.org/index.php/altex/article/view/1339
Krebs, A., Waldmann, T., Wilks, M. F., van Vugt-Lussenburg, B. M. A., van der Burg, B., Terron, A., Steger-Hartmann, T., Ruegg, J., Rovida, C., Pedersen, E., et al. (2019) · ALTEX · doi:10.14573/altex.1909271 · Cited by 77 · cited 1×
“Using these types of templates, however, still leaves to the developers and end-users the freedom to choose their preferred instrument and technique to generate the data (Krebs et al. 2019).”
Live-cell imaging powered by computation
Shroff, H., Testa, I., Jug, F., & Manley, S. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00702-6 · Cited by 75 · cited 1×
“Different image segmentation techniques are available and factors like image complexity, desired level of detail, and computational resources should be taken into consideration when selecting the best approach ( e.g., thresholding, edge detection, region growing) (Shroff et al. 2024).”
Sachana, M., Shafer, T. J., & Terron, A. (2021) · Biology · doi:10.3390/biology10020086 · Cited by 71 · cited 1×
“Recently, a DNT in vitro battery (DNT IVB) has been assembled (Sachana, Shafer, and Terron 2021; Harrill et al. 2018; Blum et al. 2023), comprising of multiple test methods assessing individual key neurodevelopmental processes (KNDPs).”
Hammer, M., Huisman, M., Rigano, A., Boehm, U., Chambers, J. J., Gaudreault, N., North, A. J., Pimentel, J. A., Sudar, D., Bajcsy, P., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01327-9 · Cited by 70 · cited 4×
“Metadata should be embedded within the image file itself or provided in supplementary files alongside the published images (Linkert et al. 2010; Hammer et al. 2021).”
InfluentialNyffeler, J., Willis, C., Harris, F. R., Foster, M. J., Chambers, B., Culbreth, M., Brockway, R. E., Davidson-Fritz, S., Dawson, D., Shah, I., et al. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116513 · Cited by 67 · cited 1×
“Over 1000 chemicals have been tested with this method so far, and the phenotypic profiles are available in the public EPA CompTox Chemicals Dashboard 5 (Nyffeler et al. 2023).”
Self-citationReproducible image handling and analysis
Miura, K., & Nørrelykke, S. F. (2021) · The EMBO Journal · doi:10.15252/embj.2020105889 · Cited by 65
Turner, O. C., Aeffner, F., Bangari, D. S., High, W., Knight, B., Forest, T., Cossic, B., Himmel, L. E., Rudmann, D. G., Bawa, B., et al. (2020) · Toxicologic Pathology · doi:10.1177/0192623319881401 · Cited by 64
Publishing and sharing multi-dimensional image data with OMERO
Burel, J.-M., Besson, S., Blackburn, C., Carroll, M., Ferguson, R. K., Flynn, H., Gillen, K., Leigh, R., Li, S., Lindner, D., et al. (2015) · Mammalian Genome · doi:10.1007/s00335-015-9587-6 · Cited by 62 · cited 2×
“Using existing image data management systems like Open Microscopy Environment Remote Objects (OMERO) (Allan et al. 2012; Burel et al. 2015; Li et al. 2016) and storing biological image datasets in repositories ( e.g., BioImage Archive, 17 IDR, 18 PIDAR 19 ) can facilitate secure data sharing and…”
Self-citationNelson, G., Boehm, U., Bagley, S., Bajcsy, P., Bischof, J., Brown, C. M., Dauphin, A., Dobbie, I. M., Eriksson, J. E., Faklaris, O., et al. (2021) · Journal of Microscopy · doi:10.1111/jmi.13041 · Cited by 60 · cited 4×
“…for standardisation in imaging technologies, organisations such as Global BioImaging 6 and QUAREP-LiMi 7 (Quality assurance and reproducibility for instrument and images in light microscopy) facilitate best practices and collaboration across stakeholders (Nelson et al. 2021; Schmied et al. 2024).”
InfluentialSelf-citationPyImageJ: A library for integrating ImageJ and Python
Rueden, C., Hiner, M., Evans, E. L., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01655-4 · Cited by 53 · cited 2×
“…et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific use cases, which can become particularly powerful when combined with open-source data analysis based on R (Meyer et al. 2024; Pau et al. 2010) or Python (Rueden et al. 2022).”
Mehrvar, S., Himmel, L. E., Babburi, P., Goldberg, A. L., Guffroy, M., Janardhan, K. S., Krempley, A. L., & Bawa, B. (2021) · Journal of Pathology Informatics · doi:10.4103/jpi.jpi_36_21 · Cited by 49 · cited 1×
“Histopathology data are essential for toxicity studies, evaluating drug-induced toxic effects in laboratory animals and its relevance for human safety, as required by regulatory authorities (Mehrvar et al. 2021).”
Metadata management for high content screening in OMERO
Li, S., Besson, S., Blackburn, C., Carroll, M., Ferguson, G., Flynn, H. C., Gillen, K., Leigh, R., Lindner, D., Linkert, M., et al. (2015) · Methods · doi:10.1016/j.ymeth.2015.10.006 · Cited by 48 · cited 2×
“Using existing image data management systems like Open Microscopy Environment Remote Objects (OMERO) (Allan et al. 2012; Burel et al. 2015; Li et al. 2016) and storing biological image datasets in repositories ( e.g., BioImage Archive, 17 IDR, 18 PIDAR 19 ) can facilitate secure data sharing and…”
Self-citationScientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation
Koch, K., Bartmann, K., Hartmann, J., Kapr, J., Klose, J., Kuchovská, E., Pahl, M., Schlüppmann, K., Zühr, E., & Fritsche, E. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.816370 · Cited by 48 · cited 2×
“For instance, the “Human Neurosphere Assay” (Koch et al. 2022) assesses chemical effects on the proliferation and differentiation of human foetal neural progenitor cells cultured as neurospheres in vitro.”
Self-citationOECD (2023) · OECD series on testing and assessment · doi:10.1787/6bb2e6ce-en · Cited by 46
IMI—Bigpicture: A Central Repository for Digital Pathology
Moulin, P., Grünberg, K., Barale-Thomas, E., et al. (2021) · Toxicologic Pathology · doi:10.1177/0192623321989644 · Cited by 44 · cited 1×
“…Bigpicture 1 offers a unified infrastructure with the tools needed to exploit the data gathered (3 million curated, quality-controlled human and animal digital slides), that can be used for research and as reference/historical control (Moulin et al. 2021; Rudmann et al. 2023; Jacobsen et al. 2021).”
Self-citationSerafini, M. M., Sepehri, S., Midali, M., Stinckens, M., Biesiekierska, M., Wolniakowska, A., Gatzios, A., Rundén‐Pran, E., Reszka, E., Marinovich, M., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03703-8 · Cited by 44 · cited 1×
“The integration of test methods identifying glia cell-specific toxicities ( i.e., astrocytes, radial glia, and microglia) and the use of exclusively human-based cell systems shall improve the DNT IVB performance in the future (Masjosthusmann et al. 2020; Serafini et al. 2024).”
OECD (2023) · OECD Series on Testing and Assessment · doi:10.1787/91964ef3-en · Cited by 44
Rigano, A., Ehmsen, S. R., Öztürk, S. U., Ryan, J., Balashov, A. K., Hammer, M., Kırlı, K., Boehm, U., Brown, C. M., Bellve, K. D., et al. (2021) · Nature Methods · doi:10.1038/s41592-021-01315-z · Cited by 43 · cited 1×
“Potential solutions include utilising electronic laboratory notebooks, while another option is to leverage instrument-integrated metadata annotation tools to minimise human error and enhance metadata quality and consistency (Rigano et al. 2021; Kunis et al. 2021; Ryan et al. 2021).”
Nelson, G., Boehm, U., Fernandez-Rodriguez, J., Ferrand, A., Gelman, L., Gheisari, A., Hartmann, H., Kukat, C., Laude, A., Mitkovski, M., et al. (2021) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · Cited by 39
Self-citationA biologist’s guide to planning and performing quantitative bioimaging experiments
Senft, R. A., Diaz-Rohrer, B. B., Colarusso, P., Swift, L. H., Jamali, N., Jambor, H. K., Pengo, T., Brideau, C., Llopis, P. D. L. M. M., Uhlmann, V., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002167 · Cited by 39 · cited 1×
“…discuss technical and biological variability, concordance with in vivo data, and frameworks for building confidence in in vitro methods for risk assessment and regulatory purposes (National Academies of Sciences and Medicine 2023; Senft et al. 2023; Negro et al. 2018; Pistollato et al. 2021).”
Self-citationAuthority), E. (. F. S., Hernandez‐Jerez, A., Coja, T., Paparella, M., Price, A., Henri, J., Focks, A., Louisse, J., Terron, A., Binaglia, M., et al. (2024) · EFSA Journal · doi:10.2903/j.efsa.2024.8759 · Cited by 37
Self-citationA perspective on Microscopy Metadata: data provenance and quality controlPreprint
Huisman, M., Hammer, M., Rigano, A., Boehm, U., Chambers, J. J., Gaudreault, N., North, A. J., Pimentel, J. A., Sudar, D., Bajcsy, P., et al. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1910.11370 · Cited by 34
Krebs, A. (2020) · ALTEX · doi:10.14573/altex.1909271e · Cited by 31
CellProfiler: Novel Automated Image Segmentation Procedure for Super-Resolution Microscopy
Soliman, K. (2015) · Biological Procedures Online · doi:10.1186/s12575-015-0023-9 · Cited by 29 · cited 1×
“Open-source solutions based on software platforms such as Fiji/ImageJ (Rueden et al. 2017), CellProfiler (Stir-ling et al. 2021; Soliman 2015) and pipelining software KNIME (Berthold et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific…”
Martin, M. M., Baker, N. C., Boyes, W. K., Carstens, K. E., Culbreth, M. E., Gilbert, M. E., Harrill, J. A., Nyffeler, J., Padilla, S., Friedman, K. P., et al. (2022) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2022.107117 · Cited by 29
Self-citationAn automated protocol for performance benchmarking a widefield fluorescence microscope
Halter, M., Bier, E., DeRose, P. C., Cooksey, G. A., Choquette, S. J., Plant, A. L., & Elliott, J. T. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22519 · Cited by 28 · cited 2×
“A more reliable approach involves calibration with standardised materials available for the fluorescent ranges commonly used in biomedical research (Halter et al. 2014; Kwee et al. 2021).”
Kolle, S. N., Moreno, M. C. R., Mayer, W., van Cott, A., van Ravenzwaay, B., & Landsiedel, R. (2015) · Alternatives to Laboratory Animals · doi:10.1177/026119291504300307 · Cited by 27
Assessing the performance of the Cell Painting assay across different imaging systems
Tromans‐Coia, C., Jamali, N., Abbasi, H. S., Giuliano, K. A., Hagimoto, M., Jan, K., Kaneko, E., Letzsch, S., Schreiner, A., Sexton, J. Z., et al. (2023) · Cytometry Part A · doi:10.1002/cyto.a.24786 · Cited by 24
Self-citationMorphological profiling data resource enables prediction of chemical compound properties
Wolff, C., Neuenschwander, M., Beese, C. J., Sitani, D., Ramos, M. C., Srovnalová, A., Varela, M. J., Полищук, П. Г., Skopelitou, K., Škuta, C., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112445 · Cited by 24
Self-citationUnderstanding the provenance and quality of methods is essential for responsible reuse of FAIR data
Weissgerber, T. L., Gazda, M. A., Nilsonne, G., ter Riet, G., Cobey, K. D., Prieß-Buchheit, J., Noro, J., Schulz, R., Tijdink, J. K., Bobrov, E., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02879-x · Cited by 23
MethodsJ2: a software tool to capture metadata and generate comprehensive microscopy methods text
Ryan, J., Pengo, T., Rigano, A., Llopis, P. D. L. M. M., Itano, M. S., Cameron, L., Marqués, G., Strambio‐De‐Castillia, C., Sanders, M. A., & Brown, C. M. (2021) · Nature Methods · doi:10.1038/s41592-021-01290-5 · Cited by 22 · cited 1×
“Potential solutions include utilising electronic laboratory notebooks, while another option is to leverage instrument-integrated metadata annotation tools to minimise human error and enhance metadata quality and consistency (Rigano et al. 2021; Kunis et al. 2021; Ryan et al. 2021).”
Reliable identification and quantification of neural cells in microscopic images of neurospheres
Förster, N., Butke, J., Keßel, H. E., Bendt, F., Pahl, M., Li, L., Fan, X., Leung, P., Klose, J., Masjosthusmann, S., et al. (2021) · Cytometry Part A · doi:10.1002/cyto.a.24514 · Cited by 21 · cited 1×
“…the differentiation and morphology of neurons, and the differentiation of oligodendrocytes is assessed based on brightfield images and immuno-cytochemical staining using the image analysis software ‘Omnisphero’ (Schmuck et al. 2017; Förster et al. 2022) and two Convolutional Neural Networks (CNN).”
Kunis, S., Hänsch, S., Schmidt, C., Wong, F., Strambio‐De‐Castillia, C., & Weidtkamp‐Peters, S. (2021) · Nature Methods · doi:10.1038/s41592-021-01288-z · Cited by 20 · cited 1×
“Potential solutions include utilising electronic laboratory notebooks, while another option is to leverage instrument-integrated metadata annotation tools to minimise human error and enhance metadata quality and consistency (Rigano et al. 2021; Kunis et al. 2021; Ryan et al. 2021).”
Jacobsen, M. C., Lewis, A. R., Baily, J. E., et al. (2021) · Toxicologic Pathology · doi:10.1177/01926233211017031 · Cited by 17 · cited 1×
“…Bigpicture 1 offers a unified infrastructure with the tools needed to exploit the data gathered (3 million curated, quality-controlled human and animal digital slides), that can be used for research and as reference/historical control (Moulin et al. 2021; Rudmann et al. 2023; Jacobsen et al. 2021).”
Klutzny, S., Kornhuber, M., Morger, A., Schönfelder, G., Volkamer, A., Oelgeschläger, M., & Dunst, S. (2021) · Environment International · doi:10.1016/j.envint.2021.106947 · Cited by 15 · cited 1×
“The term “pro-filing” is in contrast to targeted phenotypic assays such as the E-Morph Screening Assay (Klutzny et al. 2022), which give information on a pre-defined process.”
Self-citationNegro, G. D., Eskes, C., Belz, S., Bertein, C., Chlebus, M., Corvaro, M., Corvi, R., Dhalluin, S., Halder, M., Harvey, J., et al. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.08.002 · Cited by 14 · cited 1×
“…discuss technical and biological variability, concordance with in vivo data, and frameworks for building confidence in in vitro methods for risk assessment and regulatory purposes (National Academies of Sciences and Medicine 2023; Senft et al. 2023; Negro et al. 2018; Pistollato et al. 2021).”
Self-citationBuilding a nonclinical pathology laboratory of the future for pharmaceutical research excellence
Rudmann, D. G., Bertrand, L., Żuraw, A., Deiters, J., Staup, M. A., Rivenson, Y., & Kuklyte, J. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103747 · Cited by 14 · cited 1×
“…Bigpicture 1 offers a unified infrastructure with the tools needed to exploit the data gathered (3 million curated, quality-controlled human and animal digital slides), that can be used for research and as reference/historical control (Moulin et al. 2021; Rudmann et al. 2023; Jacobsen et al. 2021).”
Stokar‐Regenscheit, N., Bell, L., Berridge, B. R., Rudmann, D. G., Tagle, D. A., Hargrove-Grimes, P., Schaudien, D., Hahn, K., Kuehnlenz, J., Ashton, R. S., et al. (2024) · Toxicologic Pathology · doi:10.1177/01926233241253811 · Cited by 14
Self-citationVentral tegmental area GABA neurons integrate positive and negative valence
Stelzner, M. E., Wolff, A. R., & Saunders, B. T. (2025) · Nature Communications · doi:10.1038/s41467-025-65345-3 · Cited by 13
Research data management for bioimaging: the 2021 NFDI4BIOIMAGE community survey
Schmidt, C., Hanne, J., Moore, J., Meesters, C., Ferrando-May, E., Weidtkamp-Peters, S., & initiative, M. O. T. N. (2022) · F1000Research · doi:10.12688/f1000research.121714.2 · Cited by 12 · cited 1×
“Capturing comprehensive metadata throughout the experimental workflow remains a challenge, as highlighted in a recent survey (Schmidt et al. 2022).”
Schwenk, M., Werner, M., & Younes, M. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00457-x · Cited by 11 · cited 1×
“Extended author information available on the last page of the article environment against harmful effects of various substances (Schwenk et al. 2002).”
Sakamuru, S., Huang, R., & Xia, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935399 · Cited by 11 · cited 1×
“With a similar reasoning, the Tox21 consortium was founded by a group of US agencies with the goal of using high throughput screening to generate data on data-poor compounds for safety assessment (Richard et al. 2021; Ngan et al. 2023; Sakamuru et al. 2022).”
Meyer, L., Eling, N., & Bodenmiller, B. (2024) · BMC Bioinformatics · doi:10.1186/s12859-023-05546-z · Cited by 11 · cited 1×
“…et al. 2008) offer complete transparency of their code and are well suited to create bespoke workflows for specific use cases, which can become particularly powerful when combined with open-source data analysis based on R (Meyer et al. 2024; Pau et al. 2010) or Python (Rueden et al. 2022).”
Unleashing the potential of cell painting assays for compound activities and hazards prediction
Odje, F., Meijer, D., von Coburg, E., van der Hooft, J. J. J., Dunst, S., Medema, M. H., & Volkamer, A. (2024) · Frontiers in Toxicology · doi:10.3389/ftox.2024.1401036 · Cited by 11 · cited 1×
“The large volumes of image data generated using PP provide great opportunities to predict compound activities for human-relevant disease endpoints and to identify the underlying MoA using ML and, importantly, independent from animal experiments (Odje et al. 2024).”
Self-citationQuality criteria for in vitro human pluripotent stem cell-derived models of tissue-based cells
Pistollato, F., Bal-Price, A., Coecke, S., Parvatam, S., Pamies, D., Czysz, K., Hao, J., Kee, K., Teo, A. K. K., Niu, S., et al. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.06.003 · Cited by 10 · cited 1×
“Comple-mentarily, Good Cell Culture Practices (Pamies et al. 2022; Pistollato et al. 2022) were also developed by the research community to face challenges of advanced cellular models, including stem cells and organoids (Pamies et al. 2018), MicroPhysiological Systems and Organ-on-Chip (Pamies et…”
Ngan, D. K., Xia, M., Simeonov, A., & Huang, R. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116600 · Cited by 10 · cited 1×
“With a similar reasoning, the Tox21 consortium was founded by a group of US agencies with the goal of using high throughput screening to generate data on data-poor compounds for safety assessment (Richard et al. 2021; Ngan et al. 2023; Sakamuru et al. 2022).”
FAIR High Content Screening in Bioimaging
Hosseini, R., Vlasveld, M., Willemse, J. J., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02367-w · Cited by 10 · cited 1×
“Existing guidelines provide lists of relevant parameters, for instance: REMBI: Recommended Metadata for Biological Images, MIHCSME for high-content imaging data (Hosseini et al. 2023), 4DN-BINA-OME Microscopy Metadata Specifications (Hammer et al. 2021; Sarkans et al. 2021; Huisman et al. 2021).”
Self-citationPractical application of microsphere samples for benchmarking a quantitative phase imaging system
Kwee, E., Peterson, A., Halter, M., & Elliott, J. (2021) · Cytometry Part A · doi:10.1002/cyto.a.24291 · Cited by 9 · cited 2×
“A more reliable approach involves calibration with standardised materials available for the fluorescent ranges commonly used in biomedical research (Halter et al. 2014; Kwee et al. 2021).”
Ventral tegmental area GABA neurons integrate positive and negative valencePreprint
Stelzner, M. E., Wolff, A. R., & Saunders, B. T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.07.627330 · Cited by 5
The making of microscope camera standards
Marx, V. (2022) · Nature Methods · doi:10.1038/s41592-022-01545-9 · Cited by 3 · cited 1×
“A successful example of collaboration between QUAREP-LiMi and major camera manufacturers led, for instance, to the definition of a common vocabulary for describing scientific camera performance (Marx 2022).”
IT/QA and Regulatory Aspects of Digital Pathology: Results of the 8th ESTP International Workshop
Boisclair, J., Bawa, B., Barale-Thomas, E., et al. (2022) · Toxicologic Pathology · doi:10.1177/01926233221113275 · Cited by 3 · cited 1×
“Digital toxicological histopathology has been broadly adopted in preclinical compound development for informal consultation and peer review (Boisclair et al. 2022).”
Self-citationWolff, C., Neuenschwander, M., Beese, C. J., Sitani, D., Ramos, M. C., Srovnalová, A., Varela, M. J., Полищук, П. Г., Skopelitou, K. E., Škuta, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.27.609964 · Cited by 3 · cited 1×
“…create the worldwide largest CP-based image dataset and phenotypic profiles for hundreds of thousands of small molecules, industrial/agricultural chemicals or genetic perturbations, which will eventually become publicly available as resource datasets (Chandrasekaran et al. 2024; Wolff et al. 2024).”
Self-citationTannir, R., Chan, L., Grzywa, T. M., Arevalo, O. D., Neeser, A., Kahn, S., Cozzone, A., Olenick, L. K., Mason, N. J., & Ma, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.08.622723 · Cited by 2
Tannir, R., Chan, L., Grzywa, T. M., Arevalo, O. D., Neeser, A., Kahn, S., Cozzone, A., Ramamurthi, A., Olenick, L. K., Mason, N. J., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2025.201665 · Cited by 2
Research works printed but not linked: 2
- National Academies of Sciences, Engineering and Medicine (2023) Building confidence in new evidence streams for human health risk assessment: lessons learned from laboratory mammalian toxicity tests. The National Academies Press, Washington, DC 37579039
- OECD (2018a) Extended one-generation reproductive toxicity study (EOGRTS) (OECD TG 443). https://www.oecd-ilibrary.org/content/component/9789264304741-34-en
Cited by
Morphological profiling data resource enables prediction of chemical compound properties
Wolff, C., Neuenschwander, M., Beese, C. J., Sitani, D., Ramos, M. C., Srovnalová, A., Varela, M. J., Полищук, П. Г., Skopelitou, K., Škuta, C., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112445 · Cited by 24
Self-citationMehrtabar, S., Marey, A., Desai, A., Saad, A. M., Desai, V. S., Goñi, J., Pal, B., & Umair, M. (2025) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-025-01656-7 · Cited by 19
“Additional barriers to data sharing include the following [72, 73]: • technical incompatibilities in data formats (e.g., non-standard DICOM tags) • lack of uniform data annotation protocols • institutional reluctance to share proprietary data or patient information • lack of incentives or credit…”
New approach methodologies for risk assessment of urinary occurring toxicants
Jobst, M., Guerreiro, I., Payros, D., Oswald, I. P., Fernandes, A. S., Warth, B., & Favero, G. D. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118649 · Cited by 7
Kearney, H., Mihaila, S. M., Moroni, L., & Mota, C. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202504719 · Cited by 7
Cell painting in HepaRG cells: an interlaboratory reproducibility study
Sherer, E. A., Chen, W., Aberasturi, D. T., Sagar, K., Li, Y., Sutake, Z., Xu, J., Harris, F. R., Harrill, J., & LaRocca, J. L. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf139 · Cited by 1
Metadata
- Authors
- Piergiovanni, M., Mennecozzi, M., Barale-Thomas, E., Danovi, D., Dunst, S., Egan, D., Fassi, A., Hartley, M., Kainz, P., Koch, K., Le Dévédec, S. E., Mangas, I., Miranda, E., Nyffeler, J., Pesenti, E., Ricci, F., Schmied, C., Schreiner, A., Stokar-Regenscheit, N., Swedlow, J. R., Uhlmann, V., Wieland, F. C., Wilson, A., & Whelan, M.
- Affiliations
- European Commission (BE)
- Joint Research Centre (IT)
- Janssen (Belgium) (BE)
- King's College London (GB)
- German Federal Institute for Risk Assessment (BfR) (DE)
- European Bioinformatics Institute (GB)
- Leibniz Institute of Environmental Medicine (DE)
- European Food Safety Authority (IT)
- Axxam (Italy) (IT)
- EU-OPENSCREEN (DE)
- Revvity (United States) (US)
- University of Dundee (GB)
- University of Zurich (CH)
- AstraZeneca (United Kingdom) (GB)
- Corresponding author
- Piergiovanni, Monica
- ORCID
- Venue
- Archives of Toxicology
- Published
- 2025-02-13
- Volume
- 99
- Issue
- 4
- Pages
- 1271-1285
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- PMC
- PMC11968550
- OpenAlex
- W4407428151
- Semantic Scholar
- 8e0fade170169383d034f5ce3afcd2d4a1985c50
- Cited by
- 9
- References
- 99
- Citations by year
- 2026: 4 · 2025: 5
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Archives of Toxicology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc-nd)
- Leiden Repository (Leiden University) (submittedVersion, cc-by-nc-nd)
- OpenAgrar (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- regulatory toxicology, test method validation, quality management systems, image analysis, artificial intelligence, data management, developmental neurotoxicity, regulatory acceptance
- MeSH terms
- Animals, Artificial Intelligence, Humans, Image Processing, Computer-Assisted, Toxicology, Reproducibility of Results, Toxicity Tests, Biomedical Research, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.